Diabetes drug Actos tied to increased bladder cancer risk


The Food and Drug Administration has announced the use of the diabetes drug Actos for more than one year can increase a patient’s risk of developing bladder cancer. The agency says that it will add a new warning about the link between Actos and bladder cancer to the drug’s label later this year.

LOADING PDF: If there are any problems, click here to download the file.